ACHV

Achieve Life Sciences (ACHV)

About Achieve Life Sciences (ACHV)

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Details

Daily high

$6.75

Daily low

$6.51

Price at open

52 Week High

$7.11

52 Week Low

$2.37

Market cap

683.7M

Dividend yield

0.00%

Volume

202

Avg. volume

1.2M

P/E ratio

-5.97

Achieve Life Sciences News